Geovax to present at biotech showcase during j.p. morgan healthcare week 2024

Atlanta, ga, dec. 27, 2023 (globe newswire) -- via newmediawire - geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that david dodd, chief executive officer, will present at the biotech showcase coinciding with the 42nd annual j.p. morgan healthcare conference in san francisco, january 8-11, 2024.
GOVX Ratings Summary
GOVX Quant Ranking